There is a need for an electrically switchable, electrophoretic device that in one or more light states is transparent to visible light and provides glass-like quality and in other light states strongly attenuates light. Glass-like quality includes providing very good clarity and light transmission, very low haze, minimal perception of hue in the transparent state, and minimal diffraction. In the prior art, the available electrophoretic solutions have limitations on their functionality in some cases and inherent technological obstacles in others.
In the applicant's EP2976676 the size of apertures (transparent areas) and obstructions (light blocking areas) have their maximum size and pitch determined by the resolution of a typical viewer's eye such that apertures and obstructions are sufficiently small that their geometric form in a face view is not apparent. In examples in the document of its transparent state its black charged particles are concentrated and surround discrete transparent apertures, the maximum angle subtended by an aperture to a viewer at a required viewing distance is one arcminute (corresponding to 290 microns at a viewing distance of 1 meter) and preferably 0.6 arcminutes (corresponding to 174.5 microns at 1 meter). The subtended angle of the aperture pitch (i.e. aperture and concentrated charged particle area) can be double these limits, but only to the extent that the geometric forms are not apparent on a face view.
Similarly, in the applicant's EP3281055 it is stated that the device (including smart windows) has solid polymer structures embedded in its viewing area and the structures are on the scale of microstructure and are invisible to the eye. An example is given of a smart glass device with a cavity pitch of 250 microns. If viewing only from a long distance the document allows the cavities to be up to 1,000 microns in theory, however, the document constrains the microstructures to be not visible in use. The limiting constraint is similar to the earlier EP2976676 and is stated as the maximum angle subtended by a micro-fastener portion to a viewer at a required viewing distance is one arc minute and preferably 0.6 arc minutes.
In U.S. Pat. No. 8,183,757 it is stated that when the colorant particles are collected in the reservoir regions, the colorant particles may tint the visible areas. The tint caused by the colorant particles may prevent a neutral white or clear optical state for the displays. Devices used an opaque layer on the second electrode within each recess region. The black opaque layer in the recesses (or reservoirs) masks the coloured collected particles. In related patent U.S. Pat. No. 8,384,659 a hexagonal reservoir is shown in
In the transparent light states of prior art devices there is a perceivable tint corresponding to the colour of the charged particles in the electrophoretic ink. A viewer's perception of tint, including black tint, is one of a uniform tinting due to the micron scale, discrete distribution, and dense distribution of apertures or obstructions analogous to halftone print on paper or colour displays. The latter's pixel density is sufficiently high to ensure that individual pixels cannot be resolved even when viewed up close and that the light from adjacent pixels is integrated by the eye of a viewer seamlessly.
In embodiments a light attenuator (200, 203, 204) comprising a cell (300, 303, 304) having a first transparent substrate (190) and a second transparent substrate (190) defining respective viewing faces (150, 153, 154) and with opposite major surfaces (i.e. juxtaposed parallel) having transparent electrodes (160) and spaced apart (by dimension 5) to provide a volume there between, said volume containing transparent polymer structure (100, 103, 104) and electrophoretic ink (1, 2, 3), said ink comprising charged particles (10, 11, 12) dispersed in a transparent fluid (15, 16, 17), said charged particles are responsive to an electric field applied to said electrodes to move between: a first extreme light state in which particles are maximally spread within said cell to lie in the path of sunlight through the cell attenuating the sunlight and a second extreme light state in which said particles are maximally concentrated within the cell in locations (130, 133, 134) defined by said polymer structure to remove them from the path of sunlight through the cell transmitting the sunlight and providing visual access, and in said second light state a viewing face of said light attenuator has a visible pattern of attenuating areas (20, 24) abutted on transparent areas (30, 34) defined by the presence and absence respectively of said concentrated particles, wherein each of said abutted areas has a dimension (50, 55, 60, 65) that is 0.3 mm or more, and the centre-to-centre distance of adjacent attenuating areas (40, 41) or the centre-to-centre distance of adjacent transparent areas (45, 46) is 0.6 mm or more.
Each of said areas in said pattern subtends an angle (80, 90) of more than two arc minutes at a distance of 0.5M from said viewing face (150) and a pair of said abutted areas subtend more than four arc minutes (70).
In some embodiments the pattern is a repeating pattern and said centre-to-centre distances are the same as the pitch. The repeating pattern is a switchable grid that is visible in said second light state and indistinguishable in said first light state. In some embodiments the shortest distance or width (61) of said transparent areas is 75% or more of said pitch and the shortest distance (51) of the attenuating areas is 25% or less. Preferably the limits for the preceding rule are 80% and 20% respectively and more preferably 85% and 15%.
The transparent area in said face view of an embodiment is 60% or more of the total active (i.e., switchable) area, preferably 62% or more, more preferably 65% or more, and most preferably 70% or more, and said visible pattern comprises discontiguous and/or contiguous areas and is perceivable as a pattern of attenuating areas. The visible pattern is superposed on said visual access. The colour of the pattern or grid is the colour of said charged particles. Preferably, the superposed visible pattern or grid is designed to be aesthetically acceptable (or pleasing) by selecting the design of the locations of said concentrated charged particles in said polymer structure.
One of said areas is either: monodisperse or has a distribution of sizes and/or shapes, and preferably the shape of said areas is selected to minimize the opportunities for moiré patterns in said visual access and includes selecting shapes whose borders are defined by applying a modulation function to a geometric shape.
In some embodiments the centre-to-centre distance of adjacent attenuating areas and the centre-to-centre distance of adjacent transparent areas is 0.6 mm or more.
In some embodiments the centre-to-centre distance is in order of preference: 0.62 mm or more, 0.65 mm or more, 0.7 mm or more, 0.8 mm or more, 1.0 mm or more, and most preferably 1.25 mm or more. In correspondence to the preceding, the abutting attenuating areas and transparent areas each have one or more dimensions that are in order of preference: 0.31 mm or more, 0.325 mm or more, 0.35 mm or more, 0.4 mm or more, 0.5 mm or more, and most preferably 0.625 mm or more.
The charged particles have colourant including one or more of: a dye colorant, a pigment colourant, a strongly light scattering material, a strongly reflecting material, or a strongly absorbing material, and particles can be any colour including black or white.
The polymer structure spaces apart said substrates and divides said volume into a monolayer of discrete cavities having polymer walls and filled with said electrophoretic ink, and preferably said polymer structure includes a sealing layer sealing the ink within the cavities.
In some embodiments a colour layer is selectively applied to said polymer walls so that in said viewing face the colour of the wall area matches the colour of said charged particles.
In embodiments the locations of said concentrated charged particles are at said polymer walls, or the locations of said concentrated charged particles are in discrete reservoirs in said polymer structure and the locations do not coincide with said walls, or the locations of said concentrated charged particles are in depressions or channels between protrusions in said polymer structure and the locations may or may not coincide with said walls.
The electrophoretic ink has two or more charged particle types including: positively charged, negatively charged, differing electrophoretic mobility, and/or different colours.
The electrophoretic ink has two charged particles types each with an electrophoretic mobility and colour different to the other but the same charge polarity, and in the second light state said two types segregate as they concentrate at said locations with one type masking the other with respect to one of said viewing faces.
Preferably light attenuators provide at least one light state intermediate the first and second states by moving the charged particles between the concentrating locations in the polymer structure and the opposite electrode to vary the degree of concentrating or spreading respectively.
A device including one of: a window, a mirror, a light shutter, a light modulator, a variable light transmittance sheet, a variable light absorptance sheet, a variable light reflectance sheet, an electrophoretic sun visor for a vehicle, or a see-through display, incorporating the light attenuator.
Embodiments of the invention will now be described, by way of example, with reference to the accompanying drawings, in which:
Embodiments achieve improved optical quality in its electrophoretic light attenuators by making its particles visible as a pattern, or grid-like structure, or array, in its transparent light state. In this state the coloured charged particles are concentrated in defined areas by a transparent polymer structure so that areas in between transmit light. In the prior art neither the concentrated particle areas nor the transparent areas were resolvable, but, in embodiments both areas can be resolved as distinct by eye from at least 1M away. Embodiments minimize the integration of both areas by a viewer so that the scene viewed through the attenuator is significantly less tainted with the colour of, or haze from, the charged particles. A viewer's perception of the face of an embodiment is of clear glass with a coloured grid (or array) structure. The latter can be selected to be aesthetically pleasing. Furthermore, by selecting the scale of the pattern or grid-like structure (or array) to be visible, a light attenuator made with white particles does not appear to be hazy, rather, it appears as a foreground white grid superposed on the background scene. In addition, diffraction of light is greatly reduced by using a visible scale for the design of the transparent light state.
Embodiments are described with reference to the drawings. In
In the figures the light attenuators (200, 203, 204) of embodiments comprise an electrophoretic cell (300, 303, 304) that has two transparent substrates (190) with each coated on one side with a transparent electrode (160). The electrodes' major surfaces face each other and are juxtaposed parallel as shown in
In the second extreme light state (shown in
The second light state of cell (303) shown in
In
Similarly, in
The 0.6 mm centre-to-centre dimension is sufficiently large to be visible at 1.0M by a viewer with a visual acuity of 1.0 or higher as the viewing distance results in an angular resolution of two minutes of arc. The pattern is visible because the attenuating areas corresponding to the concentrated particles in the second light state form resolvable parts (or features) when they have a centre-to-centre distance of 0.6 mm or more and transparent area in the space between adjacent attenuating areas. A visual analogy can be made with the graduation pattern on a steel rule; graduations having a centre-to-centre distance of 0.5 mm (i.e. 0.5 mm divisions) are visible.
While the dimensions of each area of attenuating (20) and transparent (30) abutting areas should be at least 0.3 mm or more to be discernible to a viewer at 1.0M, and have a centre-to-centre dimension of at least 0.6 mm, it is also necessary that the dimension of the each area of attenuating (20) and transparent (30) abutting areas should not be so large that the pigment loading of the transparent area cannot be packed into the attenuating area. This is because, in most configurations, the area above the transparent area increases as the square of the dimension, while the surface area of the attenuating area, where the particles will be packed, increases roughly linearly with the dimension. If the dimension grows too big, the particles cannot be effective packed in the attenuating area, leading to a darker clear state. Larger dimensions are also found to require higher voltages to achieve good clearing. Experience with various sized of dimensions suggests that the area of attenuating (20) and transparent (30) abutting areas should not exceed 3 cm. The corresponding maximum centre-to-centre dimension is about 6 cm. Thus, each repeat of attenuating (20) and transparent (30) abutting areas should have a dimension (50, 55 and 60, 65) between 0.3 mm and 3 cm, while the centre-to-centre distance (40, 41) of adjacent attenuating areas or the centre-to-centre distance (45, 46) of adjacent transparent areas is between 0.6 mm and 6 cm.
In embodiments, in the second light state, and for a plurality of instances, the centre-to-centre distance of adjacent attenuating areas, or the centre-to-centre distance of adjacent transparent areas is in order of preference: 0.62 mm to 5.8 cms, 0.65 mm to 5.5 cms, 0.7 mm to 5.14 cms, 0.8 mm to 4.5 cms, 1.0 mm to 3.6 cms, and most preferably 1.25 mm to 3 cms, and in correspondence to the preceding, the abutting attenuating areas and transparent areas each have one or more dimensions that are in order of preference: 0.31 mm to 2.9 cms, 0.325 mm to 2.75 cms, 0.35 mm to 2.57 cms, 0.4 mm to 2.25 cms, 0.5 mm to 1.8 cms, and most preferably 0.625 mm to 1.5 cms.
In embodiments the transparent area in the face view is 60% or more of the total active (i.e., switchable) area, preferably 62% or more, more preferably 65% or more, and most preferably 70% or more. The attenuating area is the remainder in each case. The transparent areas, the attenuating areas, and accordingly the resolvable parts and pattern in the second light state, are defined by a device's polymer structure.
In an example shown in
The corresponding calculation for subtended angles (80) and (90) at the minimum 0.3 mm dimension within the visible pattern in embodiments is 2.06 minutes of arc:
As a consequence of the subtended angles for (70), (80) and (90) being a multiple of the minimum resolution of a viewer (with acuity 1.0) there is an obvious visible pattern when viewing embodiment (200) at 0.5M. Attenuating area (20) (comprising black concentrated particles (10)) can be seen as a black grid (or array) with clear openings analogous with a metal mesh having comparable openings and walls. Objects viewed through the embodiment have a negligible perception of black hue because the viewer's eye does not integrate the black grid area with the view through the transparent areas.
By contrast, the motivation of the prior art electrophoretic, light attenuator devices that have polymer structure throughout their electro-optical layers is to arrange their structures so that the structures (or associated patterns in the light states defined by the structures) are sufficiently small that they cannot be perceived by a viewer. In the applicant's EP2976676, the size of apertures (transparent areas) and obstructions (light blocking areas) have their maximum size and pitch (analogous to the repeating centre-to-centre distance) determined by the resolution of a typical viewer's eye so that at a viewing distance of 0.5M, its areas subtend an angle of less than one arc minute and this equates to less than 0.145 mm to avoid a pattern being apparent to a viewer.
In embodiments, in the second light state, the centre-to-centre distance of attenuating areas or transparent areas (defined by the presence or absence respectively of the concentrated particles that in turn are defined by the polymer structure) can be random or have more than one value. In other embodiments the centre-to-centre distances repeat uniformly in a direction and are the same as the pitch of the repeating pattern that is visible by eye.
In embodiment (200) the transparent areas (30) are discrete and the attenuating area (20) is contiguous, see
In the second light state the visible pattern formed by the attenuating and transparent areas in a face of embodiments is superposed on the view through the face. The visible pattern is in the foreground and the view is in the background. The eye resolves the visible pattern as a grid (or array) and perceives it as a grid of opaque areas that are the colour of the particles. In embodiments this grid can be made indistinguishable on the face when switched to the first light state. The charged particles in the first light state spread uniformly and opposite the locations that receive the particles as they concentrate in the second light state. Preferably, the superposed visible pattern or grid (or array) is designed to be aesthetically acceptable (or pleasing) by selecting the design of the locations of the concentrated charged particles in the polymer structure.
An embodiment's polymer structure, including the locations of the concentrated charged particles, is formed at least in part in an embossing, moulding or replicating step. Examples of moulding techniques are described in the applicant's EP2976676 titled “An Electrophoretic Device Having a Transparent Light State”. To minimize haze in embodiments the refractive index of the polymer structure (100, 103, 104) is matched to the ink's suspending fluid (15, 16, 17), preferably to within 0.005, more preferably, 0.002, and most preferably, 0.001.
The replicated polymer structure has depressions, channels, pits, recesses, or reservoirs corresponding to the attenuating areas and protrusions, funnel-like sloping surfaces, or a raised surface in between corresponding with the transparent areas. The shape of both areas in a face view as well as the centre-to-centre distance is defined by the polymer structure. Either area type (i.e., attenuating or transparent) can be monodisperse or have a distribution of sizes and/or shapes. Examples of devices having channels and protrusions can be found in the applicant's EP2976676; devices having reservoirs and funnel-like sloping surfaces in HP's U.S. Pat. No. 8,184,357; and, devices having recesses and raised surfaces in HP's U.S. Pat. No. 7,957,054. The latter refers to a dielectric layer with recesses but the dielectric layer is a polymer structure and its concentrated particles are located at recesses (or pits, voids, or holes) in the layer in its transparent light state. In an alternative embodiment the polymer structure provides walls that charged particles concentrate against in the second light state. These devices are referred to as dielectrophoretic and an example is shown in E Ink's US2018/0364542 A1.
In some embodiments the shape of areas is selected to minimize the opportunities for moiré patterns that would otherwise occur if an embodiment's opaque grid (i.e., strongly attenuating areas arranged in an array) is overlaid on a similar pattern in the background viewed through a face. To avoid or minimize moiré patterns the attenuating areas preferably avoid a pattern of continuous parallel lines. In this regard a honeycomb structure as shown in
In some embodiments two or more devices are stacked and to avoid moire patterns each device has a different grid (or array) pattern. In an embodiment example, a sunvisor in a vehicle comprises a stack of two devices to achieve very low light transmittance when both devices are operated in their respective maximum attenuating light states. The embodiment achieves a corresponding maximum light transmitting state when both devices are in their light transmitting states. To avoid moire patterns in some embodiments both devices' attenuating areas (and transparent areas) are precisely aligned, but, in preferred embodiments the shape of light attenuating areas is selected to be different between devices. For example, one device has a honeycomb structure for its attenuating area and the other device has a monodisperse shape such as spherical, or one whose border is modulated by a Sine wave.
In embodiment (203) shown in
In embodiments the cell gap (dimension (5) in
Preferably, a colour layer is selectively applied to the tops of polymer walls and/or posts so that in a viewing face the colour of the wall area matches the colour and light transmission of the attenuating areas in the second light state. Preferably the polymer structure includes a sealing layer or sealing mechanism that seals the fluid within each cavity. The seal layer preferably bonds to the colour layer on the polymer walls (or incorporates the colour layer). In some embodiments sealed cavities are independent of one another and can be described as cells, and the light attenuator as comprising a monolayer of cells.
In some embodiments the polymer structure locates the concentrated charged particles against or by its polymer walls including in channels adjacent its walls in the second light state. In such embodiments there are concentrated particles on each side of a polymer wall section for the respective cavities each side. Preferably the polymer walls have an attenuating layer and are coloured to match the particles; then the attenuating area for the concentrated particles will appear contiguous on a face of the device and the transparent areas will be discrete. Optionally, the polymer walls can be transparent, and if so are preferably as narrow as possible and preferably the width is in the range: 15 microns to 75 microns. In the latter case the attenuating areas in the second light state are discontiguous.
In other embodiments the polymer structure locates the concentrated charged particles in discrete reservoirs that do not coincide with the walls in the second light state. The attenuating areas are discrete and surrounded by contiguous transparent area. Preferably the walls are as narrow as possible and remain transparent so that the attenuating area in the second light state appears contiguous. Alternatively, the walls may have a colour layer.
In more preferred embodiments the concentrated charged particles are in depressions or channels between protrusions in the polymer structure and the locations may or may not coincide with the walls. The transparent areas are discrete and the attenuating areas are contiguous. Preferably the walls have an attenuating layer in embodiments where they coincide with locations of the concentrated particles, or, are transparent where they do not.
Cavities can contain a single transparent area and a single attenuating area or a plurality of either, or a part of either. Cavities can be uniform and repeat with a pitch or have differences. The centre-to-centre distance between adjacent cavities can be greater than, equal to, or less than, the centre-to-centre distance of transparent or attenuating areas defined by the concentrated charged particles in the second light state. The polymer walls of cavities can also form a visible grid on a face of embodiments but this grid is not switchable. It will be appreciated that it is advantageous to have polymer walls that have an attenuating layer arranged adjacent the locations of concentrated particles where possible. Alternatively, it is advantageous to have transparent walls arranged predominantly in transparent areas of the second light state.
In some cells a colour mask (i.e., a colour layer) different to the colour of the charged particles is selectively applied to a surface of the polymer structure in the locations where particles are concentrated in the second light state (i.e. the attenuating areas). The colour mask areas correspond to the attenuating areas and consequently in embodiments form a visible pattern or grid. In the viewing face on the same side as the colour mask the colour of the locations masks the colour of the concentrated charged particles in the second light state. An embodiment having white charged particles can avoid diffuse reflection from its attenuating areas (i.e. the concentrated charged particles areas) in the second light state by masking these areas with a black mask printed on the polymer structure, or on a face of the substrate on the same side. Alternatively the colour mask could be applied to the opposing area on the polymer structure or the opposite substrate to mask from the other viewing face. Similarly, both sides can be selectively printed to mask or minimize diffuse reflection or transmission from the concentrated particle area in the second light state. The colour mask is defined in embodiments by the locations (130, 133, 134) in the polymer structure (100, 103, 104) that define the concentrated charged particles (10, 11) in the second light state and consequently is visible by eye when viewed from the face it is adjacent to.
In embodiments the electrophoretic ink can have one, two, or more types of charged particles including: positively charged, negatively charged, differing electrophoretic mobility, and/or different colours, or any combination of these. The charged particles have colourant including one or more of: a dye colorant, a pigment colourant, a strongly light scattering material, a strongly reflecting material, or a strongly absorbing material. In some embodiments the electrophoretic ink has two charged particles types, each with an electrophoretic mobility and colour different to the other but the same charge polarity. In the second light state the two types segregate as they concentrate at the locations in the polymer structure with one type masking the other with respect to the viewing faces on the same side. This is an alternative to applying a colour mask to the locations as described in the previous paragraph. A minority of black charged particles with higher electrophoretic mobility can be used to mask a different colour of charged particle such as a majority of white particles having a lower electrophoretic mobility.
Preferably light attenuators provide at least one light state intermediate the first and second states by moving the charged particles between the concentrating locations in the polymer structure and the opposite electrode to vary the degree of concentrating or spreading respectively. A visible pattern will be apparent in intermediate light states once particles begin to concentrate in the locations provided. In embodiments where the charged particles are a colour other than black (e.g., white) haze will be at a minimum in the second light state and increase the closer an intermediate light state is to the first light state. In some embodiments the first light state is very strongly hazy to provide a privacy function.
Number | Date | Country | Kind |
---|---|---|---|
1914105 | Sep 2019 | GB | national |
1914933 | Oct 2019 | GB | national |
This application is a continuation of U.S. patent application Ser. No. 17/034,998, filed Sep. 28, 2020, which claims priority to Great Britain Patent Application No. 1914105.0, filed Sep. 30, 2019 and to Great Britain Patent Application No. 1914933.5, filed Oct. 16, 2019. All references, patents, and patent applications disclosed herein are incorporated by reference in their entireties. The present invention relates to an electrophoretic device having a construction that provides transparent light states for use in selectively controlling light, especially for smart glass applications.
Number | Name | Date | Kind |
---|---|---|---|
4418346 | Batchelder | Nov 1983 | A |
5115346 | Lynam | May 1992 | A |
5784136 | Ando et al. | Jul 1998 | A |
5872552 | Gordon, II et al. | Feb 1999 | A |
5930026 | Jacobson | Jul 1999 | A |
5961804 | Jacobson | Oct 1999 | A |
6017584 | Albert et al. | Jan 2000 | A |
6067185 | Albert et al. | May 2000 | A |
6120588 | Jacobson | Sep 2000 | A |
6120839 | Comiskey et al. | Sep 2000 | A |
6130774 | Albert et al. | Oct 2000 | A |
6144361 | Gordon, II et al. | Nov 2000 | A |
6172798 | Albert et al. | Jan 2001 | B1 |
6184856 | Gordon, II et al. | Feb 2001 | B1 |
6225971 | Gordon, II et al. | May 2001 | B1 |
6241921 | Jacobson et al. | Jun 2001 | B1 |
6249271 | Albert et al. | Jun 2001 | B1 |
6262706 | Albert et al. | Jul 2001 | B1 |
6262833 | Loxley et al. | Jul 2001 | B1 |
6271823 | Gordon, II | Aug 2001 | B1 |
6300932 | Albert | Oct 2001 | B1 |
6323989 | Jacobson et al. | Nov 2001 | B1 |
6327072 | Comiskey et al. | Dec 2001 | B1 |
6377387 | Duthaler et al. | Apr 2002 | B1 |
6392785 | Albert et al. | May 2002 | B1 |
6392786 | Albert | May 2002 | B1 |
6459418 | Comiskey et al. | Oct 2002 | B1 |
6515649 | Albert et al. | Feb 2003 | B1 |
6538801 | Jacobson et al. | Mar 2003 | B2 |
6580545 | Morrison et al. | Jun 2003 | B2 |
6623662 | Wang et al. | Sep 2003 | B2 |
6639580 | Kishi et al. | Oct 2003 | B1 |
6652075 | Jacobson | Nov 2003 | B2 |
6693620 | Herb et al. | Feb 2004 | B1 |
6721083 | Jacobson et al. | Apr 2004 | B2 |
6727881 | Albert et al. | Apr 2004 | B1 |
6822782 | Honeyman et al. | Nov 2004 | B2 |
6831771 | Ho et al. | Dec 2004 | B2 |
6839158 | Albert et al. | Jan 2005 | B2 |
6866760 | Paolini, Jr. et al. | Mar 2005 | B2 |
6870661 | Pullen et al. | Mar 2005 | B2 |
6914713 | Chung et al. | Jul 2005 | B2 |
6922276 | Zhang et al. | Jul 2005 | B2 |
6927892 | Ho et al. | Aug 2005 | B2 |
6950220 | Abramson et al. | Sep 2005 | B2 |
6956690 | Yu et al. | Oct 2005 | B2 |
6958848 | Cao et al. | Oct 2005 | B2 |
6958849 | Chen et al. | Oct 2005 | B2 |
6982178 | LeCain et al. | Jan 2006 | B2 |
6987603 | Paolini, Jr. et al. | Jan 2006 | B2 |
7002728 | Pullen et al. | Feb 2006 | B2 |
7012600 | Zehner et al. | Mar 2006 | B2 |
7012735 | Honeyman | Mar 2006 | B2 |
7038655 | Herb et al. | May 2006 | B2 |
7052766 | Zang et al. | May 2006 | B2 |
7061663 | Cao et al. | Jun 2006 | B2 |
7071913 | Albert et al. | Jul 2006 | B2 |
7072095 | Liang et al. | Jul 2006 | B2 |
7075502 | Drzaic et al. | Jul 2006 | B1 |
7079305 | Paolini, Jr. et al. | Jul 2006 | B2 |
7109968 | Albert et al. | Sep 2006 | B2 |
7110162 | Wu et al. | Sep 2006 | B2 |
7110164 | Paolini, Jr. et al. | Sep 2006 | B2 |
7113323 | Ho et al. | Sep 2006 | B2 |
7116318 | Amundson et al. | Oct 2006 | B2 |
7116466 | Whitesides et al. | Oct 2006 | B2 |
7141688 | Feng et al. | Nov 2006 | B2 |
7142351 | Chung et al. | Nov 2006 | B2 |
7144942 | Zang et al. | Dec 2006 | B2 |
7170670 | Webber | Jan 2007 | B2 |
7180649 | Morrison et al. | Feb 2007 | B2 |
7184197 | Liang et al. | Feb 2007 | B2 |
7202991 | Zhang et al. | Apr 2007 | B2 |
7224511 | Takagi | May 2007 | B2 |
7226550 | Hou et al. | Jun 2007 | B2 |
7226966 | Kambe et al. | Jun 2007 | B2 |
7230750 | Whitesides et al. | Jun 2007 | B2 |
7230751 | Whitesides et al. | Jun 2007 | B2 |
7236290 | Zhang et al. | Jun 2007 | B1 |
7236291 | Kaga et al. | Jun 2007 | B2 |
7242513 | Albert et al. | Jul 2007 | B2 |
7247379 | Pullen et al. | Jul 2007 | B2 |
7256766 | Albert et al. | Aug 2007 | B2 |
7277218 | Hwang et al. | Oct 2007 | B2 |
7286279 | Yu et al. | Oct 2007 | B2 |
7304634 | Albert et al. | Dec 2007 | B2 |
7307779 | Cernasov | Dec 2007 | B1 |
7312784 | Baucom et al. | Dec 2007 | B2 |
7312916 | Pullen et al. | Dec 2007 | B2 |
7321459 | Masuda et al. | Jan 2008 | B2 |
7327511 | Whitesides et al. | Feb 2008 | B2 |
7339715 | Webber et al. | Mar 2008 | B2 |
7375875 | Whitesides et al. | May 2008 | B2 |
7382514 | Hsu et al. | Jun 2008 | B2 |
7387858 | Chari et al. | Jun 2008 | B2 |
7390901 | Yang et al. | Jun 2008 | B2 |
7391555 | Albert et al. | Jun 2008 | B2 |
7405865 | Ogiwara et al. | Jul 2008 | B2 |
7411719 | Paolini, Jr. et al. | Aug 2008 | B2 |
7411720 | Honeyman et al. | Aug 2008 | B2 |
7420549 | Jacobson et al. | Sep 2008 | B2 |
7432907 | Goden | Oct 2008 | B2 |
7453445 | Amundson | Nov 2008 | B2 |
7473782 | Yang et al. | Jan 2009 | B2 |
7477444 | Cao et al. | Jan 2009 | B2 |
7507449 | Chari et al. | Mar 2009 | B2 |
7532388 | Whitesides et al. | May 2009 | B2 |
7532389 | Li et al. | May 2009 | B2 |
7535624 | Amundson et al. | May 2009 | B2 |
7560004 | Pereira et al. | Jul 2009 | B2 |
7561324 | Duthaler et al. | Jul 2009 | B2 |
7572394 | Gu et al. | Aug 2009 | B2 |
7576904 | Chung et al. | Aug 2009 | B2 |
7580180 | Ho et al. | Aug 2009 | B2 |
7679814 | Paolini, Jr. et al. | Mar 2010 | B2 |
7715088 | Liang et al. | May 2010 | B2 |
7746544 | Comiskey et al. | Jun 2010 | B2 |
7767112 | Hou et al. | Aug 2010 | B2 |
7839564 | Whitesides et al. | Nov 2010 | B2 |
7848006 | Wilcox et al. | Dec 2010 | B2 |
7848007 | Paolini, Jr. et al. | Dec 2010 | B2 |
7903319 | Honeyman et al. | Mar 2011 | B2 |
7910175 | Webber | Mar 2011 | B2 |
7929198 | Lipovetskaya et al. | Apr 2011 | B2 |
7951938 | Yang et al. | May 2011 | B2 |
7952790 | Honeyman et al. | May 2011 | B2 |
7955532 | Liang et al. | Jun 2011 | B2 |
7957054 | Yeo et al. | Jun 2011 | B1 |
7986297 | Ohshima et al. | Jul 2011 | B2 |
7999787 | Amundson et al. | Aug 2011 | B2 |
8009348 | Zehner et al. | Aug 2011 | B2 |
8018640 | Whitesides et al. | Sep 2011 | B2 |
8018642 | Yeo et al. | Sep 2011 | B2 |
8035886 | Jacobson | Oct 2011 | B2 |
8054535 | Sikharulidze et al. | Nov 2011 | B2 |
8089687 | Mabeek et al. | Jan 2012 | B2 |
8115729 | Danner et al. | Feb 2012 | B2 |
8119802 | Moonen et al. | Feb 2012 | B2 |
8129655 | Jacobson et al. | Mar 2012 | B2 |
8179590 | Mabeck et al. | May 2012 | B1 |
8183757 | Mabeck et al. | May 2012 | B2 |
8184357 | Yeo et al. | May 2012 | B2 |
8199395 | Whitesides et al. | Jun 2012 | B2 |
8257614 | Gu et al. | Sep 2012 | B2 |
8270064 | Feick et al. | Sep 2012 | B2 |
8305341 | Arango et al. | Nov 2012 | B2 |
8319759 | Jacobson et al. | Nov 2012 | B2 |
8331014 | Liu et al. | Dec 2012 | B2 |
8331016 | Shitagami et al. | Dec 2012 | B2 |
8361620 | Zang et al. | Jan 2013 | B2 |
8363306 | Du et al. | Jan 2013 | B2 |
8384659 | Yeo et al. | Feb 2013 | B2 |
8390918 | Wilcox et al. | Mar 2013 | B2 |
8432598 | Yeo et al. | Apr 2013 | B2 |
8446664 | Chen et al. | May 2013 | B2 |
8582196 | Walls et al. | Nov 2013 | B2 |
8593718 | Comiskey et al. | Nov 2013 | B2 |
8654436 | Feick | Feb 2014 | B1 |
8810895 | No et al. | Aug 2014 | B2 |
8896906 | Zhou et al. | Nov 2014 | B2 |
8902491 | Wang et al. | Dec 2014 | B2 |
8961831 | Du et al. | Feb 2015 | B2 |
9005494 | Valianatos et al. | Apr 2015 | B2 |
9052564 | Sprague et al. | Jun 2015 | B2 |
9104083 | Tamoto et al. | Aug 2015 | B2 |
9114663 | Ho et al. | Aug 2015 | B2 |
9158174 | Walls et al. | Oct 2015 | B2 |
9217906 | Yeo et al. | Dec 2015 | B2 |
9244326 | Zhou et al. | Jan 2016 | B2 |
9279906 | Kang | Mar 2016 | B2 |
9341915 | Yang et al. | May 2016 | B2 |
9348193 | Hiji et al. | May 2016 | B2 |
9361836 | Telfer et al. | Jun 2016 | B1 |
9366935 | Du et al. | Jun 2016 | B2 |
9372380 | Du et al. | Jun 2016 | B2 |
9382427 | Du et al. | Jul 2016 | B2 |
9423666 | Wang et al. | Aug 2016 | B2 |
9428649 | Li et al. | Aug 2016 | B2 |
9441122 | Zhou et al. | Sep 2016 | B2 |
9557623 | Wang et al. | Jan 2017 | B2 |
9567995 | Briggs et al. | Feb 2017 | B2 |
9645467 | Yokokawa et al. | May 2017 | B2 |
9658373 | Downing | May 2017 | B2 |
9664978 | Arango et al. | May 2017 | B2 |
9670367 | Li et al. | Jun 2017 | B2 |
9688859 | Yezek et al. | Jun 2017 | B2 |
9726957 | Telfer et al. | Aug 2017 | B2 |
9777201 | Widger et al. | Oct 2017 | B2 |
9778537 | Wang et al. | Oct 2017 | B2 |
9816501 | Briggs et al. | Nov 2017 | B2 |
9835926 | Sprague et al. | Dec 2017 | B2 |
9921451 | Telfer et al. | Mar 2018 | B2 |
10067398 | O'Keeffe | Sep 2018 | B2 |
10106018 | Martens et al. | Oct 2018 | B2 |
10144275 | Gaddis et al. | Dec 2018 | B2 |
10324353 | O'Keeffe | Jun 2019 | B2 |
10372008 | Telfer et al. | Aug 2019 | B2 |
10444590 | Duthaler et al. | Oct 2019 | B2 |
10509242 | O'Keeffe | Dec 2019 | B2 |
10656493 | Heikenfeld et al. | May 2020 | B2 |
10761395 | Du et al. | Sep 2020 | B2 |
10809590 | Widger et al. | Oct 2020 | B2 |
10824025 | O'Keeffe | Nov 2020 | B2 |
10852615 | Koch et al. | Dec 2020 | B2 |
10926859 | Beard et al. | Feb 2021 | B2 |
10935818 | Lam et al. | Mar 2021 | B2 |
10983410 | Widger et al. | Apr 2021 | B2 |
11098206 | Wu et al. | Aug 2021 | B2 |
11174328 | Abbott, Jr. et al. | Nov 2021 | B2 |
11454855 | Abbott, Jr. et al. | Sep 2022 | B2 |
20030048522 | Liang et al. | Mar 2003 | A1 |
20030151029 | Hsu et al. | Aug 2003 | A1 |
20030164480 | Wu et al. | Sep 2003 | A1 |
20040030125 | Li et al. | Feb 2004 | A1 |
20050012980 | Wilcox et al. | Jan 2005 | A1 |
20050156340 | Valianatos et al. | Jul 2005 | A1 |
20070091417 | Cao et al. | Apr 2007 | A1 |
20080130092 | Whitesides et al. | Jun 2008 | A1 |
20090009852 | Honeyman et al. | Jan 2009 | A1 |
20090122389 | Whitesides et al. | May 2009 | A1 |
20090206499 | Whitesides | Aug 2009 | A1 |
20090225398 | Duthaler et al. | Sep 2009 | A1 |
20090290208 | Murata | Nov 2009 | A1 |
20100148385 | Balko et al. | Jun 2010 | A1 |
20110217639 | Sprague | Sep 2011 | A1 |
20110286081 | Jacobson | Nov 2011 | A1 |
20120049125 | Du et al. | Mar 2012 | A1 |
20120118198 | Zhou et al. | May 2012 | A1 |
20130161565 | Laxton | Jun 2013 | A1 |
20130193385 | Li et al. | Aug 2013 | A1 |
20130244149 | Wang et al. | Sep 2013 | A1 |
20140011913 | Du et al. | Jan 2014 | A1 |
20140078024 | Paolini, Jr. et al. | Mar 2014 | A1 |
20140078573 | Comiskey et al. | Mar 2014 | A1 |
20140078576 | Sprague | Mar 2014 | A1 |
20140078857 | Nelson et al. | Mar 2014 | A1 |
20140104674 | Ting et al. | Apr 2014 | A1 |
20140231728 | Du et al. | Aug 2014 | A1 |
20140293399 | Kimura et al. | Oct 2014 | A1 |
20150177590 | Laxton | Jun 2015 | A1 |
20150185509 | Wang et al. | Jul 2015 | A1 |
20150277205 | Kawahara et al. | Oct 2015 | A1 |
20150301425 | Du et al. | Oct 2015 | A1 |
20160026061 | O'Keeffe | Jan 2016 | A1 |
20160170106 | Wang et al. | Jun 2016 | A1 |
20180031942 | Koch et al. | Feb 2018 | A1 |
20220282567 | Koch | Sep 2022 | A1 |
Number | Date | Country |
---|---|---|
1828350 | Sep 2006 | CN |
103834285 | Jun 2014 | CN |
2003222913 | Aug 2003 | JP |
2004163818 | Jun 2004 | JP |
20130078094 | Jul 2013 | KR |
20160052092 | May 2016 | KR |
1999010767 | Mar 1999 | WO |
2019021578 | Jan 2019 | WO |
Entry |
---|
Kitamura, T. et al., “Electrical toner movement for electronic paper-like display”, Asia Display/IDW '01, pp. 1517-1520, Paper HCS1-1 (2001). |
Yamaguchi, Y. et al., “Toner display using insulative particles charged triboelectrically”, Asia Display/IDW '01, pp. 1729-1730, Paper AMD4-4 (2001). |
Wang, D.W. et al., “Microencapsulated electric ink using gelatin/gum arabic”, Journal of Microencapsulation, vol. 26:1, pp. 37-45, (2009). |
Korean Intellectual Property Office, PCT/US2020/053110, International Search Report and Written Opinion, dated Jan. 15, 2021. |
United Kingdom Intellectual Property Office, “Combined Search and Examination Report under Sections 17 and 18(3)”, Application No. GB1914933 5, dated Apr. 16, 2020. |
Number | Date | Country | |
---|---|---|---|
20230053654 A1 | Feb 2023 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 17034998 | Sep 2020 | US |
Child | 17975735 | US |